4.5 Review

The Role of Genetic Risk Factors in Pathogenesis of Childhood-Onset Systemic Lupus Erythematosus

Journal

CURRENT ISSUES IN MOLECULAR BIOLOGY
Volume 45, Issue 7, Pages 5981-6002

Publisher

MDPI
DOI: 10.3390/cimb45070378

Keywords

childhood-onset systemic lupus erythematosus; monogenic systemic lupus erythematosus; genetics; pathogenesis

Ask authors/readers for more resources

The pathogenesis of childhood-onset systemic lupus erythematosus (cSLE) involves genetic risk factors, epigenetic mechanisms, and environmental triggers. While cSLE is typically considered a polygenic disease, rare cases with a single gene mutation provide valuable insights into the disease mechanism and aid in targeted treatment strategies. This review aims to provide an overview of monogenic and polygenic SLE, emphasizing the implications of specific genes in disease pathogenesis. Understanding the genetic factors involved in SLE may improve our understanding of disease mechanisms, identify biomarkers, and guide appropriate therapies.
The pathogenesis of childhood-onset systemic lupus erythematosus (cSLE) is complex and not fully understood. It involves three key factors: genetic risk factors, epigenetic mechanisms, and environmental triggers. Genetic factors play a significant role in the development of the disease, particularly in younger individuals. While cSLE has traditionally been considered a polygenic disease, it is now recognized that in rare cases, a single gene mutation can lead to the disease. Although these cases are uncommon, they provide valuable insights into the disease mechanism, enhance our understanding of pathogenesis and immune tolerance, and facilitate the development of targeted treatment strategies. This review aims to provide a comprehensive overview of both monogenic and polygenic SLE, emphasizing the implications of specific genes in disease pathogenesis. By conducting a thorough analysis of the genetic factors involved in SLE, we can improve our understanding of the underlying mechanisms of the disease. Furthermore, this knowledge may contribute to the identification of effective biomarkers and the selection of appropriate therapies for individuals with SLE.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available